50%/50% revenue sharing agreement for Multikine sales in Saudi Arabia upon receipt of Breakthrough Medicine Designation Amarox to act as the local regulatory representative and lead all communications with the Saudi Food and Drug Authority (SFDA)Amarox ranked #1 for SFDA applications for critical and unavailable medicine for 3 consecutive yearsAmarox to be exclusive commercial distributor of Multikine in Saudi Arabia, upon SFDA approval, with optional expansion to GCC countri
